Lucie Poulin

Title: Lucie Poulin: Innovator in Plant-Based Biotechnology

Introduction

Lucie Poulin is a prominent inventor based in California, known for her contributions to the field of plant-based biotechnology. With a total of 2 patents, she has made significant strides in the production of viral-like particles using plants.

Latest Patents

One of her latest patents focuses on the production of picornavirus-like particles (PVLP) in plants. This innovative method involves introducing a first nucleic acid and a second nucleic acid into a plant, a portion of the plant, or a plant cell. The first nucleic acid contains a regulatory region active in the plant, linked to a nucleotide sequence encoding a polyprotein. The second nucleic acid also has a regulatory region active in the plant, linked to a nucleotide sequence encoding one or more proteases. The plant or plant cell is then incubated under conditions that allow for the expression of these nucleic acids, resulting in the production of PVLPs.

Career Highlights

Lucie has worked with Medicago Inc., a company based in Quebec, Canada, where she has applied her expertise in biotechnology. Her work has contributed to advancements in the field, particularly in the area of plant-based vaccine production.

Collaborations

Throughout her career, Lucie has collaborated with notable colleagues, including Marc-Andre D'Aoust and Pierre-Olivier Lavoie. These partnerships have further enhanced her research and development efforts in biotechnology.

Conclusion

Lucie Poulin is a trailblazer in the field of plant-based biotechnology, with her innovative methods paving the way for future advancements. Her work exemplifies the potential of using plants in the production of viral-like particles, contributing to the broader field of biotechnology.